Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023

Rheumatology

  • You have access
    Making best use of bone turnover markers to monitor oral bisphosphonate therapy
    Sarah Keller, MD
    Cleveland Clinic Journal of Medicine January 2023, 90 (1) 32-34; DOI: https://doi.org/10.3949/ccjm.90a.22092

    Clinical applications of bone turnover markers can include determining when to start or end a bisphosphonate “holiday” and measuring treatment response.

  • You have access
    Nontuberculous mycobacterial musculoskeletal infections: Recognizable, when suspected
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 355-356; DOI: https://doi.org/10.3949/ccjm.89b.07022

    Two articles in this issue offer valuable insight into when to suspect these infections in patients who present with swollen, indurated, peripheral soft-tissue structures.

  • You have access
    Dactylitis from Mycobacterium intracellulare infection
    Hayato Shimizu, MD, Takumi Hashimura, MD and Hiroaki Nishioka, MD, PhD
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 360-362; DOI: https://doi.org/10.3949/ccjm.89a.21067

    A 69-year-old man presents with 6 months of progressive swelling of the right middle finger, with no systemic symptoms.

  • You have access
    Unraveling a challenging diagnosis: Role of a TNF inhibitor
    Soumya Chatterjee, MD, MS, FRCP, FACP, FACR
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 368-370; DOI: https://doi.org/10.3949/ccjm.89a.21128

    Painful swelling of the dorsum of the right hand had been diagnosed as chronic cutaneous sarcoidosis with tenosynovitis, treated unsuccessfully with prednisone and methotrexate.

  • You have access
    Treating anemia: It’s not just the EPO
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 174-175; DOI: https://doi.org/10.3949/ccjm.89b.04022

    Long-term effects of treatment with the new oral inhibitors of prolyl hydroxylase will need to be carefully monitored, as prolyl hydroxylase is a key structural component of diverse proteins.

  • You have access
    Oral hyperpigmentation with weakness and salt-craving
    Joseph Zhou, MD and S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 180-181; DOI: https://doi.org/10.3949/ccjm.89a.21036

    The patient’s primary care physician had attributed the hyperpigmentation on the lower lip and inner cheek to pen ink.

  • Anemia of chronic kidney disease: Will new agents deliver on their promise?
    You have access
    Anemia of chronic kidney disease: Will new agents deliver on their promise?
    Tarek Souaid, MD, Jonathan Taliercio, DO, James F. Simon, MD, MBA, Ali Mehdi, MD, MEd and Georges N. Nakhoul, MD, MEd
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 212-222; DOI: https://doi.org/10.3949/ccjm.89a.21100

    A review of the pathophysiology of anemia of chronic kidney disease, major clinical trials, and novel therapies.

  • You have access
    Potential systemic benefits of shocking or blocking nerves
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2022, 89 (3) 119-120; DOI: https://doi.org/10.3949/ccjm.89b.03022

    What has really caught my attention is the expanding research on controlled regional neuromodulation and its impact on systemic physiology and inflammation.

  • Stellate ganglion block as a treatment for vasomotor symptoms: Clinical application
    You have access
    Stellate ganglion block as a treatment for vasomotor symptoms: Clinical application
    Yeonsoo Sara Lee, BS, Christopher Wie, MD, Scott Pew, MD and Juliana M. Kling, MD, MPH
    Cleveland Clinic Journal of Medicine March 2022, 89 (3) 147-153; DOI: https://doi.org/10.3949/ccjm.89a.21032

    Hormone therapy is the mainstay of treatment, but there is a clear need for safe and effective nonhormonal options. The authors review data on the use of stellate ganglion block in perimenopausal and postmenopausal patients.

  • You have access
    Vitamin D supplementation: Pearls for practicing clinicians
    Susan E. Williams, MS, RD, MD, CCD, FACE, FAND
    Cleveland Clinic Journal of Medicine March 2022, 89 (3) 154-160; DOI: https://doi.org/10.3949/ccjm.89a.21021

    A review of how to assess and counsel patients on the use of vitamin D, with patient scenarios clinicians are likely to encounter, and an overview of current recommendations for vitamin D supplementation.

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 15
  • Adolescent Medicine
  • Allergy/Immunology
  • Anticoagulation
  • Cardiology
  • Covid-19
  • Critical Care
  • Dermatology
  • Diabetes
  • Drug Therapy
  • Electrophysiology
  • Emergency Medicine
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • Genetics
  • Geriatrics
  • Hematology
  • Hepatology
  • Hospice & Palliative Medicine
  • Hospital Medicine
  • Imaging
  • Infectious Diseases
  • Medical Humanities
  • Medical Humanities/Ethics
  • Men's Health
  • Mental Health
  • Nephrology
  • Neurology
  • Obesity
  • Oncology
  • Pain
  • Physical Exam
  • Practice Management
  • Preventive Care
  • Pulmonology
  • Rehabilitation Medicine
  • Rheumatology
  • Sleep Medicine
  • Surgery/Surgery Subspecialties
  • Vascular Medicine
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2026 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire